Weight-Loss Upstart Viking Needs a Deal to Vie With Lilly and Novo [BNN Bloomberg (Canada)]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: BNN Bloomberg
Viking's shares have more than tripled this year, briefly reaching a nearly $10 billion market valuation. Fueling the stock's climb were results from a mid-stage trial of the biotech's experimental weight loss shot as well an early look at a pill formulation that could eventually compete with the top-selling medicines from Eli Lilly & Co. and Novo Nordisk A/S. Wall Street is upbeat on the chances of approval for Viking's therapy, but, manufacturing and selling such a medicine promises to be a challenge for the small-cap contender. So far even the established drugmakers have struggled to meet demand — allowing compounding pharmacies to make cheaper copycat versions in the interim. Read more: Hims Debuts $199 Weight-Loss Shots at 85% Discount to Wegovy “As a small biotech company, the typical route for commercialization is they partner with others or they sell the company,” said Roger Song, an analyst at Jefferies. The likelihood of a deal “is even higher just because obesity is
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk (NVO) Advances While Market Declines: Some Information for Investors [Yahoo! Finance]Yahoo! Finance
- Eli Lilly unveils new manufacturing plant for GLP-1 pens [Yahoo! Finance]Yahoo! Finance
- Eli Lilly and Novo Nordisk are a 'duopoly' in GLP-1 market [Yahoo! Finance]Yahoo! Finance
- Eli Lilly and Novo Nordisk are a 'duopoly' in GLP-1 market [Yahoo! Finance Canada]Yahoo! Finance Canada
- Earnings Growth & Price Strength Make Novo Nordisk (NVO) a Stock to Watch [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 5/3/24 - Beat
NVO
Sec Filings
- 6/10/24 - Form 6-K
- 6/3/24 - Form 6-K
- 5/28/24 - Form 6-K
- NVO's page on the SEC website